We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Prescription drug buyers in the U.S. can find cheaper medicines at their local pharmacy than they can through importing drugs from Canada, according to a recent cost analysis performed by the FDA.
The U.S. is facing a severe shortage of flu shots after regulators in the UK suspended influenza vaccine maker Chiron’s license to manufacture Fluvirin.
Johnson & Johnson (J&J) said its subsidiary, Ortho Biotech Products, has received a subpoena from HHS’ Office of the Inspector General (OIG) requesting documents related to the sales and marketing of its Rx anemia treatment Procrit
The NIH has implemented a one-year moratorium on all staff consulting with pharmaceutical and biotechnology companies — a move that accelerates NIH’s earlier proposal to reduce employee conflicts of interest.
Following a similar decision in August, the National Institutes of Health (NIH) has rejected a petition by an advocacy group seeking to break patents on Pfizer’s glaucoma drug Xalatan so that licenses could be issued for generic competition.
Brand pharmaceutical prices under the Medicare prescription drug discount card are 12 percent to 21 percent less than the national average, according to an updated study by the Centers for Medicare & Medicaid Services (CMS).
Minnesota and Hawaii have become the latest states to receive HHS approval to join an existing purchasing pool that includes Michigan, Vermont, New Hampshire, Alaska and Nevada.
The Centers for Medicare & Medicaid Services (CMS) is encouraging states to band together to negotiate deeper discounts from pharmaceutical firms on prescription drugs purchased under the Medicaid program.
HHS is posting online prices of more than four dozen drugs in several therapeutic classes with the intention of fostering competition that will encourage pharmaceutical firms to lower prices for the products.
Citing the potential for hundreds of millions of dollars in savings, HHS' Office of the Inspector General (OIG) has urged the Centers for Medicare & Medicaid Services (CMS) to slash reimbursement rates for home oxygen equipment beginning in 2005.